Skip to main content
. Author manuscript; available in PMC: 2017 Nov 28.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Jul 12;85(3):686–692. doi: 10.1016/j.ijrobp.2012.05.023

Fig. 1.

Fig. 1

Estimated survival-time curves for biochemical relapse-free survival (bRFS), distant metastasis-free survival (DMFS), and prostate cancer-specific mortality (PCSM). a) bRFS, unadjusted; b) DMFS, unadjusted; c) PCSM, unadjusted using Fine and Gray’s test.